Advocacy Briefs

The National Coalition for LGBT Health’s LGBT Health Advocacy Briefs are designed education members of the Coalition, LGBTQ+ community, providers, and legislators on pressing federal and state health policy issues impacting the LGBTQ+ community.

The Coalition also distributes action alerts to its network to encourage members to call/write representatives or participate in sign-on letters, comment periods, and amicus briefs. Sign-up here to receive regular updates.

Advocacy Briefs

Oregon State Legislature to Allow Pharmacists to Prescribe PrEP and PEP drugs Along the lines of expanding access to (and better utilization of) routine care

Read More »

Advocacy Briefs

Washington State Legislature Moves to Address Medicaid Drug Access and creates STI/PrEP/PEP Workgroup In Washington state (WA), a collective sense of relief was felt when

Read More »

Advocacy Briefs

May is Hepatitis Awareness Month The most common types of viral hepatitis in the US are Hepatitis A, B, and C. According to the Centers

Read More »

Advocacy Briefs

Biden Administration Reinstates ACA Protections for Transgender and All LGBTQ People On Monday, May 10th, the Biden administration reinstated Obama-era protections included in the Patient

Read More »

Advocacy Briefs

TennCare III Medicaid Program – April 2021 On January 8, 2021, CMS approved a waiver request from Tennessee that transitions nearly all of its TennCare

Read More »

Advocacy Briefs

Gilead Sciences Proposes Change to Patient Assistance Program – April 2021 On April 8th, Gilead Sciences (Gilead) proposed a change to its Advancing Access Patient

Read More »

Advocacy Briefs

A Freeze on the Trump-Era Drug “Rebate Rule” Stalls – April 2021 In recent years, the federal government has called for increased review (and transparency)

Read More »

Advocacy Briefs

CMS Administrator Nomination Stalls – April 2021 The confirmation of President Joe Biden’s nomination to lead the Centers for Medicare & Medicaid Services (CMS) was

Read More »

Advocacy Briefs

Democrats Reintroduce H.R.3., their Lower Drug Pricing Act – April 2021 In essence, H.R.3 would allow the federal government to negotiate directly with drug companies

Read More »
Copyright © 2021 National Coalition for LGBT Health | All rights reserved.